Next Article in Journal
Motion in the ER3BP Under a Heterogeneous Triaxial Primary and a Modified Newtonian Force of the Secondary
Previous Article in Journal
Experimental Investigation of the Moment–Rotation Behaviour and Rotational Stiffness of Aluminium Gutter–Steel Column Connections in Multi-Span Glasshouses
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Numerical Prediction of Physicochemical Properties of Drug Structures via Some Graph Parameters

by
Mukaddes Ökten Turacı
Department of Mathematics, Faculty of Science, Pamukkale University, 20160 Denizli, Türkiye
Symmetry 2026, 18(9), 1492; https://doi.org/10.3390/sym18091492
Submission received: 31 July 2026 / Revised: 2 September 2026 / Accepted: 4 September 2026 / Published: 6 September 2026

Abstract

Graph theory has become a fundamental mathematical framework with broad applications across various scientific fields, such as biology, network security, computer science, and chemistry. A specialized branch known as chemical graph theory employs graph-based mathematical principles to model and analyze molecular architectures. Typically, molecular graphs are generated from 2D representations of chemical structures, where physicochemical properties play a decisive role in interpreting a molecule’s physical and chemical behavior. Structural symmetry within these molecular graphs significantly aids in deriving fundamental graph parameters. Recently, a novel theoretical method has been introduced to perform a comparative analysis of seven significant domination parameters alongside the p-electronic energy of benzenoid hydrocarbons. In the field of graph theory, the independence, covering, and domination numbers stand as fundamental parameters. Inspired by this methodology and related research, this study presents an exploratory investigation into the physicochemical properties of 10 selected drug and bioactive molecules from diverse therapeutic classes to evaluate bulk size-dependent properties using these fundamental graph parameters. Various regression models were evaluated alongside leave one out cross validation (LOOCV) diagnostics for six specific properties of these compounds: boiling point (BP), enthalpy of vaporization (EV), flash point (FP), molar refractivity (MR), polarizability (P), and molar volume (MV). The results highlight the potential of these fundamental graph parameters in QSPR modeling, establishing an exploratory proof of concept that warrants future support from more comprehensive independent datasets.

1. Introduction

Graph theory is recognized as an indispensable mathematical foundation that finds application in many disciplines, from chemistry and network security to computer science and biology. Modeling complex systems using vertices and edges to represent entities and their interactions allows for the rigorous structural analysis of various phenomena. Particularly within the scope of chemical graph theory, graphs are used to symbolize molecular skeletons; in these models, atoms are represented by vertices and chemical bonds by edges [1,2,3].
One of the most critical tools in this field is the topological index, a numerical identifier derived from a molecular graph that remains invariant under graph isomorphism. These indices serve as a bridge between a molecule’s geometric architecture and its physicochemical properties, such as boiling point, enthalpy, and biological activity, with these relationships frequently studied through quantitative structure–property relationship (QSPR) models [4,5]. These indices are categorized based on specific graph attributes, leading to the development of various classes such as degree-based, eccentricity-based, and temperature-based indices. Recently, these parameters have enabled the accurate prediction of physicochemical properties for many chemical molecules. In addition, these computational methods have spurred extensive scientific research focusing on both the fundamental theoretical properties of chemical molecules and their practical applications [6,7].
Let G = ( V ( G ) , E ( G ) ) be an undirected simple graph such that V ( G ) = n and E ( G ) = m . The subsequent section delineates the core definitions and terminology essential for a comprehensive analysis of the graph theoretical characteristics discussed in this research. In a graph G, the open and closed neighborhoods of a vertex v are signified by N G ( v ) and N G [ v ] , respectively. The vertex degree, denoted by d e g G ( v ) , is defined as the number of edges incident to v. In terms of neighborhood sets, d e g G ( v ) is determined by the size of the open neighborhood, such that d e g G ( v ) = N G ( v ) . The maximum and minimum vertex degrees are denoted by Δ ( G ) and δ ( G ) , respectively [8]. For any two vertices u , v V ( G ) , the distance d G u , v signifies the length of the shortest path connecting them. The maximum of these shortest paths across all vertex pairs is defined as the diameter of the graph, denoted by d i a m ( G ) . Additionally, the eccentricity of a vertex u, indicated by ε G ( u ) , represents the greatest distance from the vertex u to any other vertex v within G [9].
The foundational topological index in chemical graph theory is the Wiener index, initially proposed by H. Wiener [10]. From a mathematical perspective, it is characterized as the semi-sum of the distances between every pair of vertices within a graph G, that is,
W ( G ) = 1 2 i = 1 n j = 1 n d G ( v i , v j )
Following its inception, a diverse array of topological indices, classified primarily into degree-based and eccentricity-based categories, has been developed to capture various structural attributes of molecular frameworks. Some papers about these topological indices include [11,12,13,14,15,16,17,18].
In graph theory, a dominating set S V ( G ) for a graph G = ( V ( G ) , E ( G ) ) is defined as a vertex subset where every vertex in V ( G ) \ S is adjacent to at least one vertex in S . The smallest possible size of such a set is termed the domination number, denoted by γ ( G ) [9]. Building on the theoretical framework established by Khan (2023), who correlated seven key domination parameters with the p-electronic energy of benzenoid hydrocarbons [19], Khan et al. (2025) expanded this research by examining the relationship between these parameters and various physicochemical properties [20]. By calculating these domination values for 22-lower benzenoid hydrocarbons, their study adhered to the statistical methodology proposed by Khan [19]. Most recently, in 2026, Sankaran and Chidambaram bridged the gap between chemical graph theory and domination theory by investigating dominating energy. This metric is derived from the sum of the absolute eigenvalues of a graph’s dominating matrix. Their research further explores specialized variants, such as total, connected, and distance-based hop dominating energies. By incorporating Estrada and Resolvent versions of these indices, the authors evaluated their predictive accuracy against the p-electronic energy and 12 physical properties of 35 benzenoid hydrocarbons using multiple regression models, ranging from linear to cubic analyses [21]. In [22], the authors determine the values of six critical domination parameters for a specific class of benzenoid hydrocarbon compounds and investigate their correlation with twelve standard physicochemical properties. Through a quantitative structure–property relationship (QSPR) analysis, the research demonstrates that the locating domination number outperforms other parameters, showing a robust and strong correlation with most physicochemical properties [22].
Common eye conditions such as conjunctivitis, glaucoma, dry eyes, and allergies significantly affect an individual’s visual comfort and overall quality of life. A wide range of medications are used to manage these conditions, including antihistamines, decongestants, anti-inflammatory drugs, and antibiotics. These medications are often formulated as topical drops or ointments to provide localized treatment while minimizing potential side effects in the body [23]. The following section details the chemical structures and clinical applications of selected compounds, predominantly those targeting eye diseases, alongside various systemic, dermatological, hormonal, and excipient molecules. Detailed information on these medications can be found in article [23].
Acoramidis, which combats transthyretin amyloidosis, prevents the formation of harmful fibrils by stabilizing the TTR protein structure. This protein-preserving approach is promising, especially for patients with cardiac involvement, and studies on the drug’s efficacy are ongoing [23,24]. The chemical structure and molecular structure of Acoramidis are denoted by G 1 and M G 1 , respectively. Furthermore, they are shown in Figure 1.
Azelastine is an advanced antihistamine used in sprays and eye drops to treat allergies. It works by blocking H1 receptors and stabilizing mast cells, which reduces the overall release of allergic mediators. Compared to older drugs, it acts faster, lasts longer, and causes significantly less drowsiness. Its dual-action approach makes it a robust treatment for various allergic conditions [23,25]. The chemical structure and molecular structure of Azelastine are denoted by G 2 and M G 2 , respectively. Furthermore, they are shown in Figure 2.
Bimatoprost is a synthetic compound that mimics the body’s natural prostaglandins and is used to lower eye pressure. It balances high pressure by accelerating the outflow of fluid from the eye, thereby assisting glaucoma patients. Furthermore, since its ability to stimulate eyelash growth was discovered, it is also widely preferred for cosmetic purposes [23,26]. The chemical structure and molecular structure of Bimatoprost are denoted by G 3 and M G 3 , respectively. Furthermore, they are shown in Figure 3.
Butylene glycol is a type of organic alcohol used in cosmetic products to hydrate the skin. Thanks to its water-retention ability, it ensures that creams and serums make the skin softer. It helps products be absorbed more quickly by the skin and does not leave a greasy film on the face. It is generally a safe ingredient, although it can sometimes cause mild redness in very sensitive skin [23,27]. The chemical structure and molecular structure of Butylene glycol are denoted by G 4 and M G 4 , respectively. Furthermore, they are shown in Figure 4.
Cimetidine is a medication used to reduce stomach acid and treat conditions such as peptic ulcers and reflux. It stops excessive acid production by blocking specific receptors in the stomach. As one of the first drugs in its field, it created a major shift in the treatment of ulcer disease. Although it requires careful use due to its potential to interact with other medications, it remains an effective option preferred in certain cases despite modern alternatives [23,28]. The chemical structure and molecular structure of Cimetidine are denoted by G 5 and M G 5 , respectively. Furthermore, they are shown in Figure 5.
Melatonin is a naturally produced hormone that controls our body’s sleep patterns. By binding to receptors in the brain, it determines when we sleep and wake up, and it is taken as a supplement especially for conditions such as jet lag or insomnia. Thanks to its structure, this hormone reaches the brain quickly and is beneficial not only for sleep but also for supporting the immune system and protecting the body. It is generally a well-tolerated supplement that is used safely [23,29]. The chemical structure and molecular structure of Melatonin are denoted by G 6 and M G 6 , respectively. Furthermore, they are shown in Figure 6.
Originally designed as a blood pressure medication, Minoxidil is an effective topical treatment that prevents hair loss by stimulating hair follicles through its vasodilating effect. Applied once daily as a solution or foam, it supports hair growth by increasing microcirculation in the scalp [23,30]. The chemical structure and molecular structure of Minoxidil are denoted by G 7 and M G 7 , respectively. Furthermore, they are shown in Figure 7.
Olopatadine is a dual-action medication used for allergic rhinitis and eye allergies. It both stops the release of allergy-causing substances and rapidly soothes existing itching and redness. Generally used daily as eye drops or nasal sprays, this drug is well-tolerated by the body even with long-term use; it both improves symptoms and prevents new allergic reactions from occurring [23,30]. The chemical structure and molecular structure of Olopatadine are denoted by G 8 and M G 8 , respectively. Furthermore, they are shown in Figure 8.
Propylene glycol is a versatile ingredient used in food and beauty products to hold moisture and act as a solvent. Its small molecular size allows it to sink into the skin quickly, helping other ingredients work more effectively. It also makes lotions and creams feel smoother and easier to apply. Although generally considered safe, it can occasionally cause minor irritation for people with highly sensitive skin [23,31]. The chemical structure and molecular structure of Propylene glycol are denoted by G 9 and M G 9 , respectively. Furthermore, they are shown in Figure 9.
Trazodone is a medication used to treat depression and anxiety disorders by regulating the serotonin balance in the brain. Because it affects both serotonin and histamine receptors in the body, it has a strong sedative property. For this reason, although its primary purpose is treating depression, it is frequently prescribed by doctors to help patients with insomnia [23,32]. The chemical structure and molecular structure of Trazodone are denoted by G 10 and M G 10 , respectively. Furthermore, they are shown in Figure 10.
In Table 1, some physicochemical properties of the investigated drug molecules, such as their boiling point (BP), enthalpy of vaporization (EV), flash point (FP), molar refractivity (MR), polarizability (P), and molar volume (MV), are listed. These values can be verified in the ChemSpider database using the corresponding ChemSpider IDs provided in Table 2. Additionally, Table 2 presents the official CAS registry numbers, PubChem CIDs, and ChemSpider IDs for all ten compounds. These identifiers ensure the unambiguous characterization of the molecular structures under study and serve as standard reference inputs for computational software.
Inspired by previous studies [19,20,21,22], this work constructs regression models to predict the physicochemical properties of 10 different drug molecules using the fundamental graph parameters: independence number, covering number and domination number. In Section 2 of this study, the independence number, covering number, and domination number values of the graphs of the 10 different drug molecules are determined. In Section 3, regression models are constructed using the results obtained in Section 2 and the actual results of the physicochemical properties of these molecules. Finally, our results are presented in Section 4.

2. Computing Independence, Covering and Domination Numbers of Selected 10 Drug Structures

In this section, firstly, we provide the definitions of the independence number β ( G ) , covering number α ( G ) and domination number γ ( G ) of any given graph G and a theorem about β ( G ) and α ( G ) . Then, we compute the values of these parameters for the molecular graphs of the 10 different drug molecules.
Definition 1
([9]). An independent set of vertices of a graph  G  is a set of vertices of the graph  G  whose elements are pairwise nonadjacent. The independence number  β ( G )  of the graph  G  is the maximum cardinality among all independent sets of vertices of the graph  G .
Definition 2
([9]). A covering set is a subset of vertices in a graph  G  such that every edge in the graph is incident to at least one vertex in the set. The covering number  α ( G )  is the cardinality of the smallest possible covering sets in that graph  G .
Definition 3
([9,33]). A dominating set  S V ( G )  for a graph  G = ( V ( G ) , E ( G ) )  is defined as a vertex subset where every vertex in  V ( G ) \ S  is adjacent to at least one vertex in  S . The smallest possible size of such a set is termed the domination number, and it is denoted by  γ ( G ) .
Theorem 1
([9]). If  G  is a graph of order n having no isolated vertices, then  α ( G ) + β ( G ) = n .
Example 1.
Compute the independence number, covering number and domination number of the star graph   K 1 , 4 , which is shown in Figure 11.
The independent set with maximum cardinality of K 1 , 4 is { b , c , d , e } , so we obtain β ( K 1 , 4 ) = 4 . Furthermore, the covering set with minimum cardinality of K 1 , 4 is { a } ; thus, we have α ( K 1 , 4 ) = 1 . It can be easily seen that this satisfies Theorem 1 with these two results. As with the covering set of K 1 , 4 , the dominating set with minimum cardinality of K 1 , 4 is { a } ; then, γ ( K 1 , 4 ) = 1 is obtained.
Example 2.
Compute the independence number, covering number and domination number of the path graph   P 9 , which is shown in Figure 12.
The independent set with maximum cardinality of P 9 is { a , c , e , g , m } , so we obtain β ( P 9 ) = 5 . Furthermore, the covering set with minimum cardinality of P 9 is { b , d , f , h } ; thus, we have α ( P 9 ) = 4 . It can be easily seen that this satisfies Theorem 1 with these two results, that is, β ( P 9 ) + α ( P 9 ) = 5 + 4 = 9 . Then, the dominating set with minimum cardinality of the path graph P 9 is { b , e , h } ; thus, γ ( P 9 ) = 3 is obtained.
Theorem 2.
Let  M G 1  be a molecular graph of Acoramidis of order 21. Then,  β ( M G 1 ) = 11 ,  α ( M G 1 ) = 10  and  γ ( M G 1 ) = 7 .
Proof. 
The molecular graph M G 1 is shown with labeled vertices in Figure 13.
One of the independent sets with maximum cardinality of M G 1 is { 1 , 2 , 4 , 6 , 8 , 9 , 12 , 14 , 16 , 19 , 21 } , so we obtain β ( M G 1 ) = 11 . Furthermore, we have α ( M G 1 ) = 10 by Theorem 1. One of the dominating sets with minimum cardinality of M G 1 is { 3 , 4 , 7 , 12 , 14 , 16 , 20 } ; thus, γ ( M G 1 ) = 7 is obtained. □
Theorem 3.
Let  M G 2  be a molecular graph of Azelastine of order 27. Then,  β ( M G 2 ) = 14 ,  α ( M G 2 ) = 13  and  γ ( M G 2 ) = 9 .
Proof. 
The molecular graph M G 2 is shown with labeled vertices in Figure 14.
One of the independent sets with maximum cardinality of M G 2 is { 1 , 3 , 6 , 8 , 9 , 11 , 12 , 14 , 17 , 19 , 21 , 23 , 25 , 26 } , so we obtain β ( M G 2 ) = 14 . Furthermore, we have α ( M G 2 ) = 13 by Theorem 1. One of the dominating sets with minimum cardinality of M G 2 is { 2 , 4 , 6 , 10 , 14 , 16 , 19 , 21 , 24 } ; thus, γ ( M G 2 ) = 9 is obtained. □
Theorem 4.
Let  M G 3  be a molecular graph of Bimatoprost of order 30. Then,  β ( M G 3 ) = 16 ,  α ( M G 3 ) = 14  and  γ ( M G 3 ) = 10 .
Proof. 
The molecular graph M G 3 is shown with labeled vertices in Figure 15.
One of the independent sets with maximum cardinality of M G 3 is { 1 , 2 , 3 , 5 , 8 , 10 , 12 , 15 , 17 , 18 , 20 , 22 , 23 , 25 , 27 , 29 } , so we obtain β ( M G 3 ) = 16 . Furthermore, we have α ( M G 3 ) = 14 by Theorem 1. One of the dominating sets with minimum cardinality of M G 3 is { 4 , 6 , 9 , 12 , 14 , 16 , 20 , 21 , 25 , 28 } ; thus, γ ( M G 3 ) = 10 is obtained. □
Theorem 5.
Let  M G 4  be a molecular graph of Butylene glycol of order 6. Then,  β ( M G 4 ) = 4 ,  α ( M G 4 ) = 2  and  γ ( M G 4 ) = 2 .
Proof. 
The molecular graph M G 4 is shown with labeled vertices in Figure 16.
The independent set with maximum cardinality of M G 4 is { 2 , 3 , 4 , 6 } , so we obtain β ( M G 4 ) = 4 . Furthermore, we have α ( M G 4 ) = 2 by Theorem 1. The dominating set with minimum cardinality of M G 4 is { 1 , 5 } or { 1 , 6 } ; thus, γ ( M G 4 ) = 2 is obtained. □
Theorem 6.
Let  M G 5  be a molecular graph of Cimetidine of order 17. Then,  β ( M G 5 ) = 9 ,  α ( M G 5 ) = 8  and  γ ( M G 5 ) = 6 .
Proof. 
The molecular graph M G 5 is shown with labeled vertices in Figure 17.
One of the independent sets with maximum cardinality of M G 5 is { 2 , 5 , 6 , 7 , 9 , 11 , 14 , 15 , 17 } , so we obtain β ( M G 5 ) = 9 . Furthermore, we have α ( M G 5 ) = 8 by Theorem 1. One of the dominating sets with minimum cardinality of M G 5 is { 2 , 4 , 8 , 11 , 13 , 16 } ; thus, γ ( M G 5 ) = 6 is obtained. □
Theorem 7.
Let  M G 6  be a molecular graph of Melatonin of order 17. Then,  β ( M G 6 ) = 9 ,  α ( M G 6 ) = 8  and  γ ( M G 6 ) = 6 .
Proof. 
The molecular graph M G 6 is shown with labeled vertices in Figure 18.
One of the independent sets with maximum cardinality of M G 6 is { 1 , 3 , 6 , 7 , 9 , 12 , 14 , 16 , 17 } , so we obtain β ( M G 6 ) = 9 . Furthermore, we have α ( M G 6 ) = 8 by Theorem 1. One of the dominating sets with minimum cardinality of M G 6 is { 2 , 6 , 7 , 9 , 13 , 15 } ; thus, γ ( M G 6 ) = 6 is obtained. □
Theorem 8.
Let  M G 7  be a molecular graph of Minoxidil of order 15. Then,  β ( M G 7 ) = 8 ,  α ( M G 7 ) = 7  and  γ ( M G 7 ) = 5 .
Proof. 
The molecular graph M G 7 is shown with labeled vertices in Figure 19.
One of the independent sets with maximum cardinality of M G 7 is { 1 , 2 , 3 , 5 , 7 , 10 , 12 , 14 } , so we obtain β ( M G 7 ) = 8 . Furthermore, we have α ( M G 7 ) = 7 by Theorem 1. One of the dominating sets with minimum cardinality of M G 7 is { 2 , 4 , 8 , 10 , 13 } ; thus, γ ( M G 7 ) = 5 is obtained. □
Theorem 9.
Let  M G 8  be a molecular graph of Olopatadine of order 25. Then,  β ( M G 8 ) = 14 ,  α ( M G 8 ) = 11  and  γ ( M G 8 ) = 7 .
Proof. 
The molecular graph M G 8 is shown with labeled vertices in Figure 20.
One of the independent sets with maximum cardinality of M G 8 is { 1 , 2 , 4 , 6 , 8 , 10 , 12 , 14 , 16 , 18 , 20 , 22 , 24 , 25 } , so we obtain β ( M G 8 ) = 14 . Furthermore, we have α ( M G 8 ) = 11 by Theorem 1. One of the dominating sets with minimum cardinality of M G 8 is { 3 , 5 , 8 , 13 , 16 , 20 , 23 } ; thus, γ ( M G 8 ) = 7 is obtained. □
Theorem 10.
Let  M G 9  be a molecular graph of Propylene glycol of order 5. Then,  β ( M G 9 ) = 3 ,  α ( M G 9 ) = 2  and  γ ( M G 9 ) = 2 .
Proof. 
The molecular graph M G 9 is shown with labeled vertices in Figure 21.
The independent set with maximum cardinality of M G 9 is { 1 , 2 , 4 } or { 1 , 2 , 5 } , so we obtain β ( M G 9 ) = 3 . Furthermore, we have α ( M G 9 ) = 2 by Theorem 1. The dominating set with minimum cardinality of M G 9 is { 3 , 4 } or { 3 , 5 } ; thus, γ ( M G 9 ) = 2 is obtained. □
Theorem 11.
Let  M G 10  be a molecular graph of Trazodone of order 26. Then,  β ( M G 10 ) = 14 ,  α ( M G 10 ) = 12  and  γ ( M G 10 ) = 8 .
Proof. 
The molecular graph M G 10 is shown with labeled vertices in Figure 22.
One of the independent sets with maximum cardinality of M G 10 is { 1 , 3 , 4 , 6 , 8 , 10 , 12 , 14 , 16 , 19 , 20 , 22 , 24 , 26 } , so we obtain β ( M G 10 ) = 14 . Furthermore, we have α ( M G 10 ) = 12 by Theorem 1. One of the dominating sets with minimum cardinality of M G 10 is { 2 , 6 , 8 , 13 , 16 , 18 , 21 , 24 } ; thus, γ ( M G 10 ) = 8 is obtained. □
All values between Theorem 2 and Theorem 11 were verified using a computer program. Specifically, the independence numbers of 10 different molecular graphs were determined using the Paull–Unger algorithm. This algorithm identifies all maximal independent sets within a graph G and subsequently computes its independence number [34,35]. The vertex covering numbers of these molecular graphs were derived via Theorem 1. Furthermore, the domination numbers were obtained using a brute-force technique, which involves an exhaustive search of all subsets of the vertex set. Since the maximum number of vertices in these 10 molecular graphs is 30, the results were obtained within a short computational timeframe. The independence, covering and domination numbers for the 10 molecular graphs are summarized in Table 3.

3. QSPR Analysis of Selected Drug Structures Using Graph-Based Regression Models

The primary objective of this section is to enhance the quantitative structure–property relationship (QSPR) between the physicochemical characteristics of some specific drugs (namely, Acoramidis, Azelastine, Bimatoprost, Butylene glycol, Cimetidine, Melatonin, Minoxidil, Olopatadine, Propylene glycol and Trazodone) and the independence, covering, and domination numbers of their respective molecular graphs. Furthermore, this segment evaluates the analytical efficacy and predictive robustness of these graph theoretic parameters in characterizing the molecular behavior of the investigated compounds. Three graph-theoretic parameters derived from the molecular graphs of ten distinct drug molecules are employed to predict six key physicochemical properties, namely, boiling point (BP), enthalpy of vaporization (EV), flash point (FP), molar refractivity (MR), polarizability (P), and molar volume (MV). The physicochemical properties of these drugs are presented in Table 1. Furthermore, the values of independence, covering and domination numbers of 10 molecular graphs are presented in Table 3.
Linear, quadratic, and cubic regression models are then developed to relate the physicochemical characteristics of these drugs to the theoretical graph parameters of their molecular graphs. The following equations are utilized in the regression analysis:
Y = A + B X             ( Linear   regression   model )          
Y = A + B X + C X 2       ( Quadratic   regression   model )              
Y = A + B X + C X 2 + D X 3         ( Cubic   regression   model )          
Here, the response variable denotes a physicochemical property, the explanatory variable denotes a graph-theoretic parameter, and the remaining constants are regression coefficients. Furthermore, we evaluate six statistical measures, including the correlation coefficient R 2 , adjusted R 2 ( A d j . R 2 ), p-value, Root Mean Square Error (RMSE), Mean Absolute Error (MAE) and Fisher’s statistic F , to ensure a comprehensive analysis of the models.
MATLAB R2025b software was used to create linear, quadratic, and cubic regression models between the independence covering and domination, numbers of the molecular graphs of the investigated drugs (given in Table 3) and their physicochemical properties (listed in Table 1). The values of correlation coefficients obtained by linear, quadratic and cubic regression models between the graph theoretical parameters and the characteristics of the investigated drugs and bioactive molecules are displayed in Table 4, Table 5 and Table 6, respectively. Furthermore, in these tables, the highest correlation coefficient (R) for each physicochemical property is indicated in bold. Table 7, Table 8 and Table 9 present the linear, quadratic and cubic regression models for each physicochemical property with the used graph parameters yielding the highest correlation coefficient (R), along with the R 2 , A d j . R 2 , RMSE, MAE, Fisher’s statistic F and p-value. Furthermore, Figure 23, Figure 24 and Figure 25 show that the illustrations of the most appropriate and well-estimated linear, quadratic and cubic regression models for determining some physicochemical properties of the investigated drugs and bioactive molecules.
The statistical correlations observed across the regression models can be attributed to the fundamental graph theoretic definitions established in Section 2. According to Theorem 1, the independence number β ( G ) and vertex covering number α ( G ) directly scale with the total number of heavy atoms and skeletal branching, which inherently govern molecular size, surface area, and related bulk properties such as boiling point. Concurrently, the domination number γ ( G ) identifies the minimal subset of core vertices required to cover the skeletal network within distance one, effectively reflecting the central connectivity and topological compactness of the molecule. Thus, these set theoretic parameters may serve as simple yet meaningful structural descriptors of both overall molecular dimension and local vertex arrangement.
In order to assess the prediction reliability, stability, and generalizability of the established linear, quadratic, and cubic regression models, the leave one out cross validation (LOOCV) method was employed. In this validation process, a single data point is removed from the dataset to serve as the test sample while the model is calibrated on the remaining observations; this routine is systematically repeated until all samples have been predicted independently. The internal validation capacity was evaluated via the cross validated coefficient of determination ( Q 2 ), the Root Mean Square Error of cross validation (LOOCV RMSE), and the Mean Absolute Error of cross validation (LOOCV MAE). The corresponding validation metrics for the linear, quadratic, and cubic models are presented in Table 10, Table 11 and Table 12, respectively.
Across all 19 established regression models in Table 10, Table 11 and Table 12, the statistical assessment demonstrates remarkable goodness of fit and internal predictive capability, with the leave one out cross validation metrics satisfying the benchmark criteria ( Q 2 > 0.50 and R 2 Q 2 0.20 ) in 18 of the models, supporting their structural robustness and the general absence of overfitting. Only a single model among the quadratic models exhibited a slight discrepancy exceeding the conservative threshold ( R 2 = 0.8691 , Q 2 = 0.6520 , R 2 Q 2 = 0.2171 ) while still maintaining an acceptable internal predictive power ( Q 2 > 0.50 ). Overall, the coherence between the calibration ( R 2 , RMSE ) and validation ( Q 2 , LOOCV   RMSE ) statistics suggests the reliability, statistical stability, and high predictive capacity of the investigated graph parameters for the targeted physicochemical properties.

4. Conclusions

In this study, we examined the molecular graphs of ten selected drug and bioactive molecules (Acoramidis, Azelastine, Bimatoprost, Butylene glycol, Cimetidine, Melatonin, Minoxidil, Olopatadine, Propylene glycol, and Trazodone) from diverse therapeutic classes to evaluate bulk size-dependent properties using the independence number, covering number, domination number, and QSPR analysis. We presented the correlation among the graph theoretical parameters and physicochemical characteristics of these drugs and also performed their regression analysis. Correlation analysis demonstrates the chemical applicability of the graph theoretical parameters in QSPR studies to model the physicochemical properties of the investigated drugs and bioactive molecules. The analysis results indicate that the p-value in each case is less than 0.05, signifying the statistical significance of the findings. In the linear model, the most effective predictors are the covering number for the boiling point (BP) and enthalpy of vaporization (EV); the independence number for the molar refractivity (MR), polarizability (P), and molar volume (MV); and the domination number for the enthalpy of vaporization (EV) and flash point (FP). In the quadratic model, the most effective predictors are the covering number for the boiling point (BP), enthalpy of vaporization (EV), flash point (FP), and molar volume (MV) and the independence number for the molar refractivity (MR) and polarizability (P). In the cubic model, the most effective predictors are the covering number for the molar volume (MV); the independence number for the molar refractivity (MR) and polarizability (P); and the domination number for the boiling point (BP), enthalpy of vaporization (EV), and flash point (FP). Furthermore, one can observe that the cubic regression analysis generally provides a better correlation in comparison to the linear and quadratic regression analyses, which should nonetheless be evaluated cautiously as exploratory fits due to the small sample size. Additionally, leave one out cross validation (LOOCV) metrics confirmed the general absence of overfitting across the models ( Q 2 > 0.50 and R 2 Q 2 0.20 ), supporting the internal stability of the linear, quadratic, and cubic relationships. The findings of this study provide an exploratory proof of concept and useful initial insights into the structure–property relationships of the investigated therapeutic and bioactive molecules. Although the dataset examined is relatively small and structurally heterogeneous, it provides a valuable starting point for exploratory graph parameter analysis. Future studies will focus on extending this methodology to larger and more homogeneous molecular datasets. Furthermore, QSPR analyses can be conducted to predict the physicochemical properties of various drug molecules by employing fundamental graph parameters such as independence, covering, and domination numbers and their derived variants in future studies.

Funding

This research received no external funding.

Data Availability Statement

Data, including all molecular structures and properties, are taken from PubChem (https://pubchem.ncbi.nlm.nih.gov/ (accessed on 30 July 2026)) and ChemSpider (https://www.chemspider.com/ (accessed on 30 July 2026)). Furthermore, all data generated or analyzed during this study are included within this article.

Acknowledgments

The author is grateful to the editor and the anonymous reviewers for their constructive comments and valuable suggestions, which have greatly helped to improve the quality of the paper.

Conflicts of Interest

The author declares no conflicts of interest.

References

  1. Cayley, A. On the mathematical theory of isomers. Phil. Mag. 1874, 47, 444–446. [Google Scholar] [CrossRef] [Scilit]
  2. Balaban, A.T.; Devillers, J. Topological Indices and Related Descriptors in QSAR and QSPR; CRC Press: Boca Raton, FL, USA, 2014. [Google Scholar]
  3. Idrees, N.; Saif, M.J.; Anwar, T. Eccentricity-Based Topological Invariants of Some Chemical Graphs. Atoms 2019, 7, 21. [Google Scholar] [CrossRef] [Scilit]
  4. Todeschini, R.; Consonni, V. Handbook of Molecular Descriptors; Wiley-VCH: Weinheim, Germany, 2000. [Google Scholar]
  5. Cai, Z.; Zafferani, M.; Akande, O.M.; Hargrove, A.E. Quantitative structure–activity relationship (QSAR) study predicts small-molecule binding to RNA structure. J. Med. Chem. 2022, 65, 7262–7277. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  6. Ökten Turacı, M. Computing Some Eccentric Connectivity Indices Based on Vertices and Edges of Backbone DNA Graphs. Symmetry 2026, 18, 173. [Google Scholar] [CrossRef] [Scilit]
  7. Hayat, S.; Imran, M. Computation of topological indices of certain Networks. App. Math. Comput. 2014, 240, 213–228. [Google Scholar] [CrossRef] [Scilit]
  8. West, D.B. Introduction to Graph Theory; Prentice Hall: Hoboken, NJ, USA, 2001. [Google Scholar]
  9. Chartrand, G.; Lesniak, L. Graphs & Digraphs, 4th ed.; Chapman & Hall/CRC: Boca Raton, FL, USA, 2005. [Google Scholar]
  10. Wiener, H. Structural Determination of Paraffin Boiling Points. J. Am. Chem. Soc. 1947, 69, 17–20. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  11. Hayat, H.; Siddiqui, M.K.; Ahmad, S. A graph theoretical and multicriteria decision framework for physicochemical evaluation of drugs used in cancer treatment via graph energy. Chem. Pap. 2026, 80, 6947–6971. [Google Scholar] [CrossRef] [Scilit]
  12. Hayat, H.; Ahmad, S.; Siddiqui, M.K.; Petros, F.B. Predictive modeling of influenza strain drugs using temperature-based topological indices and regression analysis via multi-criteria decision-making techniques. Sci. Rep. 2026, 16, 14035. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  13. Arockiaraj, M.; Godlin, J.J.; Radha, S. Comparative study of degree and neighborhood degree sum-based topological indices for predicting physicochemical properties of skin cancer drug structures. Mod. Phys. Lett. B 2025, 39, 2550106. [Google Scholar] [CrossRef] [Scilit]
  14. Ökten Turacı, M. The values of eccentricity-based topological indices of diamond graphs. Süleyman Demirel Univ. J. Nat. Appl. Sci. 2018, 22, 285–289. [Google Scholar] [CrossRef] [Scilit]
  15. Ökten Turaci, M. On vertex and edge eccentricity-based topological indices of a certain chemical graph that represents bidentate ligands. J. Mol. Struct. 2020, 12, 127766. [Google Scholar] [CrossRef] [Scilit]
  16. Das, S.; Kumari, A.; Barman, J. On degree-dependent topological study of line graph of some antiviral COVID-19 drugs. Eur. Phys. J. E 2025, 48, 39. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  17. Nazir, S.; Siddiqui, M.K.; Hayat, H.; Gegbe, B. Exploring topological indices and power curve fitting models for predicting heat of formation in magnesium aluminate network. Sci. Rep. 2026, 16, 20590. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  18. Kara, Y.; Özkan, Y.S.; Arockiaraj, M. Computational insights and predictive models for lung cancer molecular structures. Chem. Pap. 2025, 79, 1869–1878. [Google Scholar] [CrossRef] [Scilit]
  19. Khan, S. Comparative study of domination parameters with the π-electronic energy of benzenoid hydrocarbons. Int. J. Quantum Chem. 2023, 123, e27192. [Google Scholar] [CrossRef] [Scilit]
  20. Khan, S.; Malik, M.Y.H.; Colakoglu, O.; Ishaq, M.; Faryad, U. A comparative study: Domination parameters and physico-chemical properties of benzenoid hydrocarbons. Polycycl. Aromat. Compd. 2025, 45, 793–809. [Google Scholar] [CrossRef] [Scilit]
  21. Sankaran, S.; Chidambaram, N. Exploring the properties of benzenoid hydrocarbons through QSPR modeling and domination-based energy parameters. Sci. Rep. 2026, 16, 3839. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  22. Barman, J.; Das, S. A comparative analysis of domination parameters and the physicochemical properties of benzenoid hydrocarbons. Eur. Phys. J. Plus 2025, 140, 1215. [Google Scholar] [CrossRef] [Scilit]
  23. Hashem, A.F.; Hanif, M.F.; Shafiq, A.; Alzahrani, E. TOPSIS based multi criteria QSPR modeling of antibiotics using graph theoretic indices. Sci. Rep. 2025, 15, 40658. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  24. Judge, P.D.; Alexander, K.M.; Cappelli, F.; Fontana, M.; Garcia-Pavia, P.; Gibbs, S.D.; Mahaffey, K.W.; Gillmore, J.D. Efficacy of acoramidis on all-cause mortality and cardiovascular hospitalization in transthyretin amyloid cardiomyopathy. J. Am. Coll. Cardiol. 2025, 85, 1003–1014. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  25. Cui, L.; Gao, N.; Bai, C.; Zuo, Y.; Hao, W.; Guan, K. A randomized controlled trial evaluating prophylactic treatment of Artemisia pollinosis using azelastine hydrochloride and fluticasone propionate nasal spray. Front. Allergy 2025, 6, 1559201. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  26. Mann, E.; Kammer, J.A.; Sawhney, G.; An, J.; Werts, E.C.; Vera, V.; Sonparote, S.; Craven, E.R. Prospective 18-month study of bimatoprost intracameral implant in patients with open-angle glaucoma or ocular hypertension in US clinical practice. Drugs 2025, 85, 397. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  27. Fredi, G.; Santi, S.; Soccio, M.; Lotti, N.; Dorigato, A. Electrospun Poly (butylene 2, 5-furanoate) and Poly (pentamethylene 2, 5-furanoate) Mats: Structure–Property Relationships and Thermo-Mechanical and Biological Characterization. Molecules 2025, 30, 841. [Google Scholar] [PubMed]
  28. Brown, R.; Fard, S.; Feng, P.; Kerr, P.E. Evaluation and management of benign tumors of the eye and eyelid. Clin. Dermatol. 2024, 42, 343–350. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  29. Wang, Y.; Song, Z.; Han, Q.; Luo, F.; Jiang, C.; Zhang, Z.; Hu, Z.; Ren, S. Melatonin targets the paraventricular thalamus to promote non-rapid eye movement sleep in C3H/HeJ mice. Curr. Biol. 2024, 34, 3792–3803. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  30. Zeppieri, M.; Gagliano, C.; Spadea, L.; Salati, C.; Chukwuyem, E.C.; Enaholo, E.S.; D’Esposito, F.; Musa, M. From eye care to hair growth: Bimatoprost. Pharmaceuticals 2024, 17, 561. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  31. Račić, A.; Krstonošić, V.; Micov, A.; Pecikoza, U.; Dobričić, V.; Turković, E.; Krajišnik, D. Stability and efficacy of mucoadhesive eye drops containing olopatadine HCl: Physicochemical, functional, and preclinical in vivo assessment. Pharmaceutics 2025, 17, 517. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  32. Barrow, J.; Vendrame, M. Treatment of REM sleep behavior disorder with trazodone: Report of 3 cases. J. Clin. Sleep Med. 2024, 20, 821–823. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  33. Mafuta, P. On a conjecture of Chellali and Favaron regarding connected domination numbers. Electron. J. Math. 2024, 7, 1–18. [Google Scholar] [CrossRef] [Scilit]
  34. Paull, M.C.; Unger, S.H. Minimizing the number of states in incompletely specified sequential switching functions. IRE Trans. Electron. Comput. 1959, EC-8, 356–367. [Google Scholar] [CrossRef] [Scilit]
  35. Prather, R.E. Discrete Mathematical Structures for Computer Science; Houghton Mifflin Company: Boston, MA, USA, 1976. [Google Scholar]
Figure 1. Chemical structure G 1 and molecular structure M G 1 [23].
Figure 1. Chemical structure G 1 and molecular structure M G 1 [23].
Symmetry 18 01492 g001
Figure 2. Chemical structure G 2 and molecular structure M G 2 [23].
Figure 2. Chemical structure G 2 and molecular structure M G 2 [23].
Symmetry 18 01492 g002
Figure 3. Chemical structure G 3 and molecular structure M G 3 [23].
Figure 3. Chemical structure G 3 and molecular structure M G 3 [23].
Symmetry 18 01492 g003
Figure 4. Chemical structure G 4 and molecular structure M G 4 [23].
Figure 4. Chemical structure G 4 and molecular structure M G 4 [23].
Symmetry 18 01492 g004
Figure 5. Chemical structure G 5 and molecular structure M G 5 [23].
Figure 5. Chemical structure G 5 and molecular structure M G 5 [23].
Symmetry 18 01492 g005
Figure 6. Chemical structure G 6 and molecular structure M G 6 [23].
Figure 6. Chemical structure G 6 and molecular structure M G 6 [23].
Symmetry 18 01492 g006
Figure 7. Chemical structure G 7 and molecular structure M G 7 [23].
Figure 7. Chemical structure G 7 and molecular structure M G 7 [23].
Symmetry 18 01492 g007
Figure 8. Chemical structure G 8 and molecular structure M G 8 [23].
Figure 8. Chemical structure G 8 and molecular structure M G 8 [23].
Symmetry 18 01492 g008
Figure 9. Chemical structure G 9 and molecular structure M G 9 [23].
Figure 9. Chemical structure G 9 and molecular structure M G 9 [23].
Symmetry 18 01492 g009
Figure 10. Chemical structure G 10 and molecular structure M G 10 [23].
Figure 10. Chemical structure G 10 and molecular structure M G 10 [23].
Symmetry 18 01492 g010
Figure 11. The star graph K 1 , 4 whose vertices set is V ( K 1 , 4 ) = { a , b , c , d , e } .
Figure 11. The star graph K 1 , 4 whose vertices set is V ( K 1 , 4 ) = { a , b , c , d , e } .
Symmetry 18 01492 g011
Figure 12. The path graph P 9 whose vertices set is V ( P 9 ) = { a , b , c , d , e , f , g , h , m } .
Figure 12. The path graph P 9 whose vertices set is V ( P 9 ) = { a , b , c , d , e , f , g , h , m } .
Symmetry 18 01492 g012
Figure 13. The molecular graph M G 1 whose vertices set is V ( M G 1 ) = { 1 , 2 , , 20 , 21 } .
Figure 13. The molecular graph M G 1 whose vertices set is V ( M G 1 ) = { 1 , 2 , , 20 , 21 } .
Symmetry 18 01492 g013
Figure 14. The molecular graph M G 2 whose vertices set is V ( M G 2 ) = { 1 , 2 , , 26 , 27 } .
Figure 14. The molecular graph M G 2 whose vertices set is V ( M G 2 ) = { 1 , 2 , , 26 , 27 } .
Symmetry 18 01492 g014
Figure 15. The molecular graph M G 3 whose vertices set is V ( M G 3 ) = { 1 , 2 , , 29 , 30 } .
Figure 15. The molecular graph M G 3 whose vertices set is V ( M G 3 ) = { 1 , 2 , , 29 , 30 } .
Symmetry 18 01492 g015
Figure 16. The molecular graph M G 4 whose vertices set is V ( M G 4 ) = { 1 , 2 , 3 , 4 , 5 , 6 } .
Figure 16. The molecular graph M G 4 whose vertices set is V ( M G 4 ) = { 1 , 2 , 3 , 4 , 5 , 6 } .
Symmetry 18 01492 g016
Figure 17. The molecular graph M G 5 whose vertices set is V ( M G 5 ) = { 1 , 2 , , 16 , 17 } .
Figure 17. The molecular graph M G 5 whose vertices set is V ( M G 5 ) = { 1 , 2 , , 16 , 17 } .
Symmetry 18 01492 g017
Figure 18. The molecular graph M G 6 whose vertices set is V ( M G 6 ) = { 1 , 2 , , 16 , 17 } .
Figure 18. The molecular graph M G 6 whose vertices set is V ( M G 6 ) = { 1 , 2 , , 16 , 17 } .
Symmetry 18 01492 g018
Figure 19. The molecular graph M G 7 whose vertices set is V ( M G 7 ) = { 1 , 2 , , 14 , 15 } .
Figure 19. The molecular graph M G 7 whose vertices set is V ( M G 7 ) = { 1 , 2 , , 14 , 15 } .
Symmetry 18 01492 g019
Figure 20. The molecular graph M G 8 whose vertices set is V ( M G 8 ) = { 1 , 2 , , 24 , 25 } .
Figure 20. The molecular graph M G 8 whose vertices set is V ( M G 8 ) = { 1 , 2 , , 24 , 25 } .
Symmetry 18 01492 g020
Figure 21. The molecular graph M G 9 whose vertices set is V ( M G 9 ) = { 1 , 2 , 3 , 4 , 5 } .
Figure 21. The molecular graph M G 9 whose vertices set is V ( M G 9 ) = { 1 , 2 , 3 , 4 , 5 } .
Symmetry 18 01492 g021
Figure 22. The molecular graph M G 10 whose vertices set is V ( M G 10 ) = { 1 , 2 , , 25 , 26 } .
Figure 22. The molecular graph M G 10 whose vertices set is V ( M G 10 ) = { 1 , 2 , , 25 , 26 } .
Symmetry 18 01492 g022
Figure 23. Illustrations of the most appropriate and well-estimated linear regression models for determining some physicochemical properties of the investigated drugs and bioactive molecules.
Figure 23. Illustrations of the most appropriate and well-estimated linear regression models for determining some physicochemical properties of the investigated drugs and bioactive molecules.
Symmetry 18 01492 g023aSymmetry 18 01492 g023b
Figure 24. Illustrations of the most appropriate and well-estimated quadratic regression models for determining some physicochemical properties of the investigated drugs and bioactive molecules.
Figure 24. Illustrations of the most appropriate and well-estimated quadratic regression models for determining some physicochemical properties of the investigated drugs and bioactive molecules.
Symmetry 18 01492 g024
Figure 25. Illustrations of the most appropriate and well-estimated cubic regression models for determining some physicochemical properties of the investigated drugs and bioactive molecules.
Figure 25. Illustrations of the most appropriate and well-estimated cubic regression models for determining some physicochemical properties of the investigated drugs and bioactive molecules.
Symmetry 18 01492 g025
Table 1. The physicochemical property values of 10 drug molecules.
Table 1. The physicochemical property values of 10 drug molecules.
Molecular
Graphs
Drug
Molecules
BP (°C)EV ( kJ / mol )FP (°C)MR ( cm 3 )P ( cm 3 )MV ( cm 3 )
M G 1 Acoramidis542.586.4281.975.830228
M G 2 Azelastine533.981276.711043.6304.6
M G 3 Bimatoprost629.897.9334.7122.748.6362.8
M G 4 Butylene
glycol
20751.6121.123.69.490
M G 5 Cimetidine476.274241.870.728198.2
M G 6 Melatonin512.878.426467.626.8197.6
M G 7 Minoxidil544.982.4283.454.621.6137.6
M G 8 Olopatadine52383.9270.199.639.5276.3
M G 9 Propylene
glycol
184.849107.2197.573.4
M G 10 Trazodone528.580.3273.4104.241.3278.8
Table 2. The CAS number, PubChem CID and ChemSpider ID of 10 drug molecules.
Table 2. The CAS number, PubChem CID and ChemSpider ID of 10 drug molecules.
Molecular
Graphs
Drug
Molecules
CAS NumberPubChem CIDChemSpider ID
M G 1 Acoramidis1446711-81-47146471335033544
M G 2 Azelastine58581-89-822672180
M G 3 Bimatoprost155206-00-153110274470565
M G 4 Butylene
glycol
107-88-0789613837670
M G 5 Cimetidine51481-61-927562654
M G 6 Melatonin73-31-4896872
M G 7 Minoxidil38304-91-5420110438564
M G 8 Olopatadine113806-05-652810714447647
M G 9 Propylene
glycol
57-55-6103013835224
M G 10 Trazodone19794-93-555335332
Table 3. The independence, covering, and domination numbers of 10 drug molecules.
Table 3. The independence, covering, and domination numbers of 10 drug molecules.
Molecular
Graphs
Drug
Molecules
Independence
Number
Covering
Number
Domination
Number
M G 1 Acoramidis11107
M G 2 Azelastine14139
M G 3 Bimatoprost161410
M G 4 Butylene
glycol
422
M G 5 Cimetidine986
M G 6 Melatonin986
M G 7 Minoxidil875
M G 8 Olopatadine14117
M G 9 Propylene
glycol
322
M G 10 Trazodone14128
Table 4. Correlations for the linear regression model between the experimental properties and graph theoretical parameters.
Table 4. Correlations for the linear regression model between the experimental properties and graph theoretical parameters.
Graph ParameterBPEVFPMRPMV
Independence Number ( β )0.86460.88290.87130.99400.99400.9836
Covering Number ( α )0.89880.90400.90290.99060.99040.9774
Domination Number ( γ )0.89780.90400.90410.98230.98210.9774
Table 5. Correlations for the quadratic regression model between the experimental properties and graph theoretical parameters.
Table 5. Correlations for the quadratic regression model between the experimental properties and graph theoretical parameters.
Graph ParameterBPEVFPMRPMV
Independence Number ( β )0.94570.92160.93450.99400.99400.9869
Covering Number ( α )0.95940.93220.94770.99290.99270.9883
Domination Number ( γ )0.95610.93000.94590.98240.98220.9825
Table 6. Correlations for the cubic regression model between the experimental properties and graph theoretical parameters.
Table 6. Correlations for the cubic regression model between the experimental properties and graph theoretical parameters.
Graph ParameterBPEVFPMRPMV
Independence Number ( β )0.97430.95890.97080.99420.99420.9879
Covering Number ( α )0.98780.96010.98160.99300.99280.9883
Domination Number ( γ )0.98880.96670.98370.98540.98520.9856
Table 7. Linear regression models yielding the most promising evaluation of physicochemical properties.
Table 7. Linear regression models yielding the most promising evaluation of physicochemical properties.
Linear Models R 2 A d j . R 2 RMSE MAE F p
BP = 190.9 + 31.89 α 0.80780.783869.153852.089333.634.0571 × 10−4
EV = 48.06 + 3.268 α 0.81710.79436.87275.082935.753.3111 × 10−4
EV = 44.54 + 5.153 γ 0.81720.79446.87085.187735.773.3036 × 10−4
FP = 91.38 + 24.85 γ 0.81740.794633.109022.810035.823.2893 × 10−4
MR = 6.282 + 7.947 β 0.98800.98654.10623.2200657.785.7280 × 10−9
P = 2.494 + 3.149 β 0.98800.98651.62561.2700659.145.6814 × 10−9
MV = 0.4289 + 21.01 β 0.96740.963418.055613.6963237.773.1107 × 10−7
Table 8. Quadratic regression models yielding the most promising evaluation of physicochemical properties.
Table 8. Quadratic regression models yielding the most promising evaluation of physicochemical properties.
Quadratic Models R 2 A d j . R 2 RMSE MAE F p
BP = 55.52 + 81.5 α 3.238 α 2 0.92040.897647.585831.850340.461.4246 × 10−4
EV = 38.69 + 6.701 α 0.2241 α 2 0.86910.83176.21694.206423.238.1218 × 10−4
FP = 51.44 + 36.65 α 1.365 α 2 0.89820.869126.433617.768230.873.3693 × 10−4
MR = 5.097 + 7.632 β + 0.01668 β 2 0.98800.98464.37853.1700289.271.8682 × 10−7
P = 2.005 + 3.019 β + 0.006891 β 2 0.98810.98471.73301.2493290.001.8519 × 10−7
MV = 60.67 + 8.306 α + 0.894 α 2 0.97670.970116.327312.6003146.781.9281 × 10−6
Table 9. Cubic regression models yielding the most promising evaluation of physicochemical properties.
Table 9. Cubic regression models yielding the most promising evaluation of physicochemical properties.
Cubic Models R 2 A d j . R 2 RMSE MAE F p
BP = 476.5 + 464.1 γ 70.87 γ 2 + 3.549 γ 3 0.97780.966727.148216.737688.032.3779 × 10−5
EV = 15.96 + 46.17 γ 7.283 γ 2 + 0.3785 γ 3 0.93460.90194.74633.096328.585.9703 × 10−4
FP = 221.8 + 233.7 γ 36.5 γ 2 + 1.867 γ 3 0.96770.951516.086710.073359.877.2989 × 10−5
MR = 13.35 + 11.34 β 0.4333 β 2 + 0.01597 β 3 0.98850.98284.63773.0348171.983.3090 × 10−6
P = 5.227 + 4.468 β 0.1687 β 2 + 0.006233 β 3 0.98850.98281.83661.1966172.223.2952 × 10−6
MV = 65.03 + 5.419 α + 1.325 α 2 0.01804 α 3 0.97680.965117.618612.740384.042.7238 × 10−5
Table 10. Comparison of Q 2 , LOOCV   RMSE and LOOCV   MAE across linear models.
Table 10. Comparison of Q 2 , LOOCV   RMSE and LOOCV   MAE across linear models.
PropertyGraph Parameter Q 2 LOOCV   RMSE LOOCV   MAE
BP α 0.694977.939366.1674
EV α 0.71517.67246.4579
EV γ 0.71617.65876.5407
FP γ 0.710637.284729.2129
MR β 0.98294.37563.9236
P β 0.98311.72801.5441
MV β 0.947920.430617.3620
Table 11. Comparison of Q 2 , LOOCV   RMSE and LOOCV   MAE across quadratic models.
Table 11. Comparison of Q 2 , LOOCV   RMSE and LOOCV   MAE across quadratic models.
PropertyGraph Parameter Q 2 LOOCV   RMSE LOOCV   MAE
BP α 0.795163.872548.1874
EV α 0.65208.47966.3939
FP α 0.736735.565027.0192
MR β 0.97944.80384.3527
P β 0.97971.89391.7081
MV α 0.952919.417218.2415
Table 12. Comparison of Q 2 , LOOCV   RMSE and LOOCV   MAE across cubic models.
Table 12. Comparison of Q 2 , LOOCV   RMSE and LOOCV   MAE across cubic models.
PropertyGraph Parameter Q 2 LOOCV   RMSE LOOCV   MAE
BP γ 0.943633.519428.2920
EV γ 0.74537.25475.8892
FP γ 0.915620.139617.4398
MR β 0.97435.37534.7347
P β 0.97472.11371.8420
MV α 0.900428.254224.2405
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ökten Turacı, M. Numerical Prediction of Physicochemical Properties of Drug Structures via Some Graph Parameters. Symmetry 2026, 18, 1492. https://doi.org/10.3390/sym18091492

AMA Style

Ökten Turacı M. Numerical Prediction of Physicochemical Properties of Drug Structures via Some Graph Parameters. Symmetry. 2026; 18(9):1492. https://doi.org/10.3390/sym18091492

Chicago/Turabian Style

Ökten Turacı, Mukaddes. 2026. "Numerical Prediction of Physicochemical Properties of Drug Structures via Some Graph Parameters" Symmetry 18, no. 9: 1492. https://doi.org/10.3390/sym18091492

APA Style

Ökten Turacı, M. (2026). Numerical Prediction of Physicochemical Properties of Drug Structures via Some Graph Parameters. Symmetry, 18(9), 1492. https://doi.org/10.3390/sym18091492

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop